Management of asymptomatic hyperuricemia: Integrated Diabetes & Endocrine Academy (IDEA) consensus statement.
Clicks: 404
ID: 87246
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
76.9
/100
404 views
264 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #6 of 19 articles by views in diabetes & metabolic syndrome
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The definition and management of asymptomatic hyperuricemia has been an area of controversy for many decades. Debate persists regarding the benefit of treating all cases of asymptomatic hyperuricemia and hence, unsurprisingly there are no clear clinical practice guidelines from our country.Ten members consisting of eminent physicians, endocrinologists, nephrologist and a rheumatologist were selected by the Integrated Diabetes & Endocrine Academy (IDEA) for a closed meeting with the aim to come to a consensus.A literature search was performed using PubMed and Cochrane library following which published articles in indexed peer review journals were selected.Each participant voiced their opinion after reviewing the available data and a consensus was reached after three meetings by voting.Recommendations were made on important areas such as definition, investigation and management of asymptomatic hyperuricemia.
| Reference Key |
valsaraj2020managementdiabetes
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Valsaraj, Rahul;Singh, Awadhesh Kumar;Gangopadhyay, Kalyan Kumar;Ghoshdastidar, Biswajit;Goyal, Ghanshyam;Batin, Masood;Mukherjee, Dibyendu;Sengupta, Upal;Chatterjee, Sanjay;Sengupta, Nilanjan; |
| Journal | diabetes & metabolic syndrome |
| Year | 2020 |
| DOI |
S1871-4021(20)30008-4
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.